Research suggests that natto and its derived compounds may have relevance to blood pressure regulation, with laboratory work identifying specific peptides produced during digestion of nattokinase—an enzyme found in natto—that can inhibit ACE, a protein involved in raising blood pressure. The single available study used simulated digestion, computational modeling, and network pharmacology analysis rather than human trials, so findings reflect early-stage mechanistic research rather than clinical evidence. Studies indicate a generally supportive direction for the concept that natto-derived peptides could function as blood pressure-relevant food components, but the absence of randomized controlled trials or human data means the practical significance for people remains unknown. Readers should note that laboratory and computational findings do not always translate to meaningful effects in the human body, and this area of research would benefit substantially from clinical investigation before stronger conclusions can be drawn.
Citations from PubMed and preprint sources. Match score (0-100) reflects automated search ranking, not clinical appraisal.
| Title | Type | Year | Direction | Match |
|---|---|---|---|---|
| Identification and mechanistic characterization of novel ACE-inhibitory pepti... | Other | 2026 | Supports | 100 |